Tummy Lab
A mobile tool to reduce stomach upset.
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | €0.0 | round | |
| investor investor | €0.0 | round | |
| investor | €0.0 | round | |
| N/A | N/A | Early VC | |
| Total Funding | 000k | ||
| EUR | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | (67 %) | 90 % | 38 % | (82 %) | 3076 % | (89 %) | 32 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | - | - | - | (258 %) | - | - | - |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | (3117 %) | (837 %) | (261 %) | (1987 %) | 88 % | 7 % | (15 %) |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
Tummy Lab provides a digital healthcare framework aimed at patients suffering from Irritable Bowel Syndrome (IBS).
Founded in 2014 by Anders Elfving and Anders Carling in Gothenburg, Sweden, the company has secured approximately $60K in seed funding from investors including Sahlgrenska Science Park. The venture operates within the digital health and educational software sectors.
The core of Tummy Lab's offering is a six-week digital program accessible via mobile or tablet. This program is designed to educate patients about IBS and the various factors that can influence their symptoms. The business primarily targets healthcare professionals by offering them a cost-effective treatment solution for their IBS patients. For patients, the program aims to reduce symptoms and improve their overall quality of life.
The mobile application allows users to log their dietary intake and associated symptoms. Utilizing this data, the system employs statistical analysis and machine learning to identify correlations between specific foods and the user's symptoms, thereby helping to pinpoint dietary triggers. This data collection also serves to create a clinical basis that healthcare professionals can use for further treatment decisions. The application is intended for individuals with a range of abdominal issues, including food intolerances, IBD, Crohn's disease, and gluten hypersensitivity.
Revenue is generated through a subscription-based model for access to the application and its features. The program was developed in collaboration with healthcare professionals to ensure its clinical relevance and effectiveness. The app's design incorporates features like custom illustrations and a color-coded structure to create a more user-friendly and supportive experience.
Keywords: digital therapeutics, IBS management, digestive health, food trigger tracking, symptom logger, diet analysis, healthcare professional tool, patient education, irritable bowel syndrome, gut health, mobile health, e-health, subscription service, clinical data, food intolerance, IBD support, Crohn's support, personalized diet, machine learning, Sahlgrenska Science Park